144 related articles for article (PubMed ID: 4177677)
1. [Studies on the contraceptive effects of periodic administration of mestranol 0.08mg and chlormadinone acetate 2mg (S-3850 tablets)].
Kobayashi T; Amemori Y; Watanabe T; Ichikawa T
Horumon To Rinsho; 1968 May; 16(5):403-9. PubMed ID: 4177677
[No Abstract] [Full Text] [Related]
2. Sequential mestranol-chlormadinone acetate as an oral contraceptive.
Tyler ET
Obstet Gynecol; 1966 Dec; 28(6):787-92. PubMed ID: 4162518
[No Abstract] [Full Text] [Related]
3. Fertility control with 15-8-5.
Andelman MB
Fertil Steril; 1970 Apr; 21(4):314-21. PubMed ID: 4101384
[No Abstract] [Full Text] [Related]
4. Modified sequential oral contraception employing mestranol with chlormadinone.
Tyler ET; Matsner EM; Gotlib M
Obstet Gynecol; 1969 Dec; 34(6):820-4. PubMed ID: 4189147
[No Abstract] [Full Text] [Related]
5. [Experiences with Ovosiston in a new dosage form].
Zwahr C
Dtsch Gesundheitsw; 1970 Apr; 25(14):635-9. PubMed ID: 4098545
[No Abstract] [Full Text] [Related]
6. Two thousand woman-years' experience with a sequential contraceptive. A more effective method of taking a sequential contraceptive.
Karrer MC; Smith ER
Am J Obstet Gynecol; 1968 Dec; 102(7):1029-34. PubMed ID: 4177693
[No Abstract] [Full Text] [Related]
7. Our experience with sequential estrogen-progestin treatments to inhibit ovulation.
Cittadini E; Quartararo P; Romano F
Int J Fertil; 1969; 14(2):180-7. PubMed ID: 4181574
[No Abstract] [Full Text] [Related]
8. [Experiences with different doses of Ovosiston preparations within the scope of marital and sexual counseling. Individual therapy with oral contraceptives].
Ebeling K; Kühndel K; Rothe K
Dtsch Gesundheitsw; 1971 Jan; 26(1):31-4. PubMed ID: 4106517
[No Abstract] [Full Text] [Related]
9. [Sequenz-Ovosiston as a contraceptive agent].
Zwahr C
Zentralbl Gynakol; 1972 Dec; 94(49):1722-5. PubMed ID: 4119508
[No Abstract] [Full Text] [Related]
10. [Experience in the use of chlormadinone acetate-mestranol mixed tablet (S-3850 tablet)].
Toyama J; Murata H; Itakura E; Sumi K; Sugawara T
Sanfujinka No Jissai; 1967 Apr; 16(4):364-72. PubMed ID: 4168671
[No Abstract] [Full Text] [Related]
11. [Experiences with the different dosage of Ovosiston preparations in the framework of marital and sexual counseling. Individual therapy with oral contraceptives].
Ebeling K; Kühndel K; Rothe K
Dtsch Gesundheitsw; 1971 Jan; 26(2):61-4. PubMed ID: 4106277
[No Abstract] [Full Text] [Related]
12. [Secondary effects using a new contraceptive methods. (Chlormadinone 0.5 mg. in continuous use)].
Morales Lepe C; Flores Bustamante H
Ginecol Obstet Mex; 1969 Feb; 24(148):197-202. PubMed ID: 4182917
[No Abstract] [Full Text] [Related]
13. [Oral contraception and gynecologic therapy].
Käsemann W
Med Welt; 1969 Jan; 2():107-10. PubMed ID: 4179615
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitors of human ovulation. General principles and accumulated experiences with sequential therapy based on mestranol and chlormadinone acetate].
Zorrilla E
Prensa Med Mex; 1968; 33(11):453-64. PubMed ID: 4105432
[No Abstract] [Full Text] [Related]
15. [Indications for the treatment with sequence preparations].
Breckwoldt M; Bettendorf G
Zentralbl Gynakol; 1969 Aug; 91(35):1147-50. PubMed ID: 4189508
[No Abstract] [Full Text] [Related]
16. [Comparison of changes in erythrocyte and resin tests induced by the use of Femigen-forte and Femifen (Polfa) preparations as contraceptives].
Pisarek-Miedzińska D; Czech W; Firek A
Ginekol Pol; 1974 Jan; 45(1):57-60. PubMed ID: 4131322
[No Abstract] [Full Text] [Related]
17. Inhibition of ovulation by estrogens.
Gual C; Becerra C; Rice-Wray E; Goldzieher JW
Am J Obstet Gynecol; 1967 Feb; 97(4):443-7. PubMed ID: 4163201
[No Abstract] [Full Text] [Related]
18. [Experiences with Ovosiston in marital and sexual counseling in a district hospital in the period Jan. 1, 1967-Dec. 31, 1968].
Keil G
Z Arztl Fortbild (Jena); 1970 May; 64(10):500-1. PubMed ID: 4106558
[No Abstract] [Full Text] [Related]
19. ["1st experiences with Ovosiston in a new dosage--a comparative study of oral contraception with 'old' and 'new' Ovosiston". "Experiences with Ovosiston in contraception. II. " Reply to the viewpoint of D. Kühne].
Zwahr C
Dtsch Gesundheitsw; 1970 Nov; 25(47):2247-50. PubMed ID: 4099776
[No Abstract] [Full Text] [Related]
20. [Normal sequential treatment. experiences with an 11:10 variant of the sequential method for contraception and for medical indications].
Schmidt H; Langner A; Kaiser R
Munch Med Wochenschr; 1970 Oct; 112(42):1903-13. PubMed ID: 4097638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
